John Deeken

An integrated pharmacogenomic analysis of doxorubicin response using genotype information on DMET genes

Subha Madhavan, Michael Harris, Mahlet G. Tadesse, 2013, BCB.

Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

Funda Meric-Bernstam, Ryma Benayed, Marc Ladanyi, 2018, The New England journal of medicine.

The Affymetrix DMET platform and pharmacogenetics in drug development.

John Deeken, J. Deeken, 2009, Current opinion in molecular therapeutics.

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

Rebecca Slack, John Deeken, Merrill J. Egorin, 2012, Cancer Chemotherapy and Pharmacology.